Please enable JavaScript to continue using this application.

Compare $CAMP vs $PLX | Chartloom

Compare

$CAMP vs $PLX

CAMP4 Therapeutics Corp · Protalix Biotherapeutics Inc

CAMP

CAMP4 Therapeutics Corp

PLX

Protalix Biotherapeutics Inc

Compare $CAMP vs $PLX

Comparing CAMP4 Therapeutics Corp and Protalix Biotherapeutics Inc

CAMPCAMP4 Therapeutics Corp

PLXProtalix Biotherapeutics Inc

CAMPCAMP4 Therapeutics Corp

Market cap

$196M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

19.59x

Rev growth (TTM)

40.3%

YTD performance

-37.2%

52W performance

6.5%

FCF yield

-14.7%

PLXProtalix Biotherapeutics Inc

Market cap

$224M

P/E (TTM)

12.11x

Forward P/E (NTM)

—

Forward P/S (NTM)

3.56x

Rev growth (TTM)

30.1%

YTD performance

59.8%

52W performance

8.2%

FCF yield

3.4%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CAMP

PLX

Detailed metrics comparison

CAMP

CAMP4 Therapeutics Corp

PLX

Protalix Biotherapeutics Inc

Market Cap

CAMP$196M

PLX$224M

Enterprise Value

CAMP$109M

PLX$197M

Price

CAMP$3.77

PLX$2.78

P/E Ratio

CAMPN/A

PLX12.11x

P/S Ratio

CAMP46.44x

PLX2.78x

EV/Sales

CAMP25.94x

PLX2.44x

EV/EBITDA

CAMP0.00x

PLX7.37x

P/B Ratio

CAMP8.12x

PLX3.06x

P/FCF Ratio

CAMPN/A

PLX29.21x

EV/FCF

CAMP-3.81x

PLX25.63x

PEG Ratio

CAMPN/A

PLX0.06x

Forward P/E (NTM)

CAMPN/A

PLXN/A

Forward P/S (NTM)

CAMP19.59x

PLX3.56x

Revenue (TTM)

CAMP$4M

PLX$81M

Revenue Growth (YoY)

CAMP40.3%

PLX30.1%

Forward Rev Growth

CAMP-10.8%

PLX-19.1%

Gross Margin (TTM)

CAMP35.8%

PLX69.2%

Operating Margin (TTM)

CAMP0.0%

PLX28.9%

EBITDA Margin (TTM)

CAMP-1199.3%

PLX30.8%

Net Margin (TTM)

CAMP-2543.7%

PLX23.5%

FCF Margin (TTM)

CAMP-681.2%

PLX9.5%

Net Income (TTM)

CAMP$-107M

PLX$19M

FCF (TTM)

CAMP$-29M

PLX$8M

EPS (TTM)

CAMP-$1.85

PLX$0.23

ROE (TTM)

CAMP-19474.0%

PLX31.6%

ROA (TTM)

CAMP-10642.0%

PLX20.1%

ROIC (TTM)

CAMP-19457.0%

PLX31.6%

Cash

CAMP$86M

PLX$27M

Debt

CAMP$0

PLX$0

Net Cash/Debt

CAMP$86M

PLX$27M

Current Ratio (TTM)

CAMP4.70x

PLX2.94x

Quick Ratio (TTM)

CAMP4.69x

PLX1.91x

Debt/Equity (TTM)

CAMP0.00x

PLX0.00x

Debt/Assets (TTM)

CAMP0.0%

PLX0.0%

Interest Coverage (TTM)

CAMPN/A

PLXN/A

Net Debt/EBITDA (TTM)

CAMP0.00x

PLX0.00x

Beta

CAMP-24.51

PLX-0.05

52W Performance

CAMP6.5%

PLX8.2%

YTD Performance

CAMP-37.2%

PLX59.8%

% from 52W High

CAMP-51.4%

PLX-12.9%

% from 52W Low

CAMP31.8%

PLX73.7%

Asset Turnover (TTM)

CAMP0.79x

PLX0.85x

FCF Yield (TTM)

CAMP-14.7%

PLX3.4%

Earnings Yield (TTM)

CAMP-54.8%

PLX8.5%

Dividend Yield (TTM)

CAMPN/A

PLXN/A

Rule of 40

CAMP-640.9

PLX39.7

EV/GP/RG

CAMP0.53

PLXN/A

Ticker research

View CAMP research View PLX research

Metric	CAMP CAMP4 Therapeutics Corp	PLX Protalix Biotherapeutics Inc
Market & Valuation
Market Cap	$196M	$224M
Enterprise Value	$109M	$197M
Price	$3.77	$2.78
P/E Ratio	N/A	12.11x
P/S Ratio	46.44x	2.78x
EV/Sales	25.94x	2.44x
EV/EBITDA	0.00x	7.37x
P/B Ratio	8.12x	3.06x
P/FCF Ratio	N/A	29.21x
EV/FCF	-3.81x	25.63x
PEG Ratio	N/A	0.06x
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	19.59x	3.56x
Revenue & Growth
Revenue (TTM)	$4M	$81M
Revenue Growth (YoY)	40.3%	30.1%
Forward Rev Growth	-10.8%	-19.1%
Profitability
Gross Margin (TTM)	35.8%	69.2%
Operating Margin (TTM)	0.0%	28.9%
EBITDA Margin (TTM)	-1199.3%	30.8%
Net Margin (TTM)	-2543.7%	23.5%
FCF Margin (TTM)	-681.2%	9.5%
Net Income (TTM)	$-107M	$19M
FCF (TTM)	$-29M	$8M
EPS (TTM)	-$1.85	$0.23
ROE (TTM)	-19474.0%	31.6%
ROA (TTM)	-10642.0%	20.1%
ROIC (TTM)	-19457.0%	31.6%
Financial Health
Cash	$86M	$27M
Debt	$0	$0
Net Cash/Debt	$86M	$27M
Current Ratio (TTM)	4.70x	2.94x
Quick Ratio (TTM)	4.69x	1.91x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-24.51	-0.05
52W Performance	6.5%	8.2%
YTD Performance	-37.2%	59.8%
% from 52W High	-51.4%	-12.9%
% from 52W Low	31.8%	73.7%
Efficiency & Yields
Asset Turnover (TTM)	0.79x	0.85x
FCF Yield (TTM)	-14.7%	3.4%
Earnings Yield (TTM)	-54.8%	8.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-640.9	39.7
EV/GP/RG	0.53	N/A
Ticker research	View CAMP research	View PLX research

Valuation

P/E Ratio

PLX

12.11x

P/S Ratio

PLX

2.78x

CAMP

46.44x

EV/FCF

CAMP

-3.81x

PLX

25.63x

Growth & revenue

Revenue Growth TTM

CAMP

40.3%

PLX

30.1%

Forward Revenue Growth

CAMP

-10.8%

PLX

-19.1%

Profitability & performance

Gross Margin

PLX

69.2%

CAMP

35.8%

ROE

PLX

31.6%

CAMP

-19474.0%

FCF Yield %

PLX

3.4%

CAMP

-14.7%

52-Week Performance

PLX

8.2%

CAMP

6.5%

Detailed metrics comparison

CAMP

CAMP4 Therapeutics Corp

PLX

Protalix Biotherapeutics Inc

Market Cap

CAMP$196M

PLX$224M

Enterprise Value

CAMP$109M

PLX$197M

Price

CAMP$3.77

PLX$2.78

P/E Ratio

CAMPN/A

PLX12.11x

P/S Ratio

CAMP46.44x

PLX2.78x

EV/Sales

CAMP25.94x

PLX2.44x

EV/EBITDA

CAMP0.00x

PLX7.37x

P/B Ratio

CAMP8.12x

PLX3.06x

P/FCF Ratio

CAMPN/A

PLX29.21x

EV/FCF

CAMP-3.81x

PLX25.63x

PEG Ratio

CAMPN/A

PLX0.06x

Forward P/E (NTM)

CAMPN/A

PLXN/A

Forward P/S (NTM)

CAMP19.59x

PLX3.56x

Revenue (TTM)

CAMP$4M

PLX$81M

Revenue Growth (YoY)

CAMP40.3%

PLX30.1%

Forward Rev Growth

CAMP-10.8%

PLX-19.1%

Gross Margin (TTM)

CAMP35.8%

PLX69.2%

Operating Margin (TTM)

CAMP0.0%

PLX28.9%

EBITDA Margin (TTM)

CAMP-1199.3%

PLX30.8%

Net Margin (TTM)

CAMP-2543.7%

PLX23.5%

FCF Margin (TTM)

CAMP-681.2%

PLX9.5%

Net Income (TTM)

CAMP$-107M

PLX$19M

FCF (TTM)

CAMP$-29M

PLX$8M

EPS (TTM)

CAMP-$1.85

PLX$0.23

ROE (TTM)

CAMP-19474.0%

PLX31.6%

ROA (TTM)

CAMP-10642.0%

PLX20.1%

ROIC (TTM)

CAMP-19457.0%

PLX31.6%

Cash

CAMP$86M

PLX$27M

Debt

CAMP$0

PLX$0

Net Cash/Debt

CAMP$86M

PLX$27M

Current Ratio (TTM)

CAMP4.70x

PLX2.94x

Quick Ratio (TTM)

CAMP4.69x

PLX1.91x

Debt/Equity (TTM)

CAMP0.00x

PLX0.00x

Debt/Assets (TTM)

CAMP0.0%

PLX0.0%

Interest Coverage (TTM)

CAMPN/A

PLXN/A

Net Debt/EBITDA (TTM)

CAMP0.00x

PLX0.00x

Beta

CAMP-24.51

PLX-0.05

52W Performance

CAMP6.5%

PLX8.2%

YTD Performance

CAMP-37.2%

PLX59.8%

% from 52W High

CAMP-51.4%

PLX-12.9%

% from 52W Low

CAMP31.8%

PLX73.7%

Asset Turnover (TTM)

CAMP0.79x

PLX0.85x

FCF Yield (TTM)

CAMP-14.7%

PLX3.4%

Earnings Yield (TTM)

CAMP-54.8%

PLX8.5%

Dividend Yield (TTM)

CAMPN/A

PLXN/A

Rule of 40

CAMP-640.9

PLX39.7

EV/GP/RG

CAMP0.53

PLXN/A

Ticker research

View CAMP research View PLX research

Metric	CAMP CAMP4 Therapeutics Corp	PLX Protalix Biotherapeutics Inc
Market & Valuation
Market Cap	$196M	$224M
Enterprise Value	$109M	$197M
Price	$3.77	$2.78
P/E Ratio	N/A	12.11x
P/S Ratio	46.44x	2.78x
EV/Sales	25.94x	2.44x
EV/EBITDA	0.00x	7.37x
P/B Ratio	8.12x	3.06x
P/FCF Ratio	N/A	29.21x
EV/FCF	-3.81x	25.63x
PEG Ratio	N/A	0.06x
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	19.59x	3.56x
Revenue & Growth
Revenue (TTM)	$4M	$81M
Revenue Growth (YoY)	40.3%	30.1%
Forward Rev Growth	-10.8%	-19.1%
Profitability
Gross Margin (TTM)	35.8%	69.2%
Operating Margin (TTM)	0.0%	28.9%
EBITDA Margin (TTM)	-1199.3%	30.8%
Net Margin (TTM)	-2543.7%	23.5%
FCF Margin (TTM)	-681.2%	9.5%
Net Income (TTM)	$-107M	$19M
FCF (TTM)	$-29M	$8M
EPS (TTM)	-$1.85	$0.23
ROE (TTM)	-19474.0%	31.6%
ROA (TTM)	-10642.0%	20.1%
ROIC (TTM)	-19457.0%	31.6%
Financial Health
Cash	$86M	$27M
Debt	$0	$0
Net Cash/Debt	$86M	$27M
Current Ratio (TTM)	4.70x	2.94x
Quick Ratio (TTM)	4.69x	1.91x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-24.51	-0.05
52W Performance	6.5%	8.2%
YTD Performance	-37.2%	59.8%
% from 52W High	-51.4%	-12.9%
% from 52W Low	31.8%	73.7%
Efficiency & Yields
Asset Turnover (TTM)	0.79x	0.85x
FCF Yield (TTM)	-14.7%	3.4%
Earnings Yield (TTM)	-54.8%	8.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-640.9	39.7
EV/GP/RG	0.53	N/A
Ticker research	View CAMP research	View PLX research